CA2633266C - Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same - Google Patents
Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same Download PDFInfo
- Publication number
- CA2633266C CA2633266C CA2633266A CA2633266A CA2633266C CA 2633266 C CA2633266 C CA 2633266C CA 2633266 A CA2633266 A CA 2633266A CA 2633266 A CA2633266 A CA 2633266A CA 2633266 C CA2633266 C CA 2633266C
- Authority
- CA
- Canada
- Prior art keywords
- tablet
- solid dispersion
- pharmaceutically acceptable
- fused solid
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20050124386 | 2005-12-16 | ||
| KR10-2005-0124386 | 2005-12-16 | ||
| PCT/KR2006/005526 WO2007069874A1 (en) | 2005-12-16 | 2006-12-18 | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2633266A1 CA2633266A1 (en) | 2007-06-21 |
| CA2633266C true CA2633266C (en) | 2011-08-02 |
Family
ID=38163142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2633266A Expired - Fee Related CA2633266C (en) | 2005-12-16 | 2006-12-18 | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080292702A1 (https=) |
| EP (1) | EP1968542B1 (https=) |
| JP (1) | JP2009519326A (https=) |
| CN (1) | CN101330904B (https=) |
| AU (1) | AU2006325658B2 (https=) |
| BR (1) | BRPI0619868A8 (https=) |
| CA (1) | CA2633266C (https=) |
| ES (1) | ES2429097T3 (https=) |
| IL (1) | IL191804A0 (https=) |
| NO (1) | NO339674B1 (https=) |
| NZ (1) | NZ569813A (https=) |
| RU (1) | RU2403013C2 (https=) |
| WO (1) | WO2007069874A1 (https=) |
| ZA (1) | ZA200806138B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060119971A (ko) | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
| KR101005391B1 (ko) * | 2008-07-22 | 2010-12-30 | 한국콜마 주식회사 | 덱시부프로펜 함유 서방출성 시럽제 및 그의 제조방법 |
| KR101067224B1 (ko) * | 2008-07-22 | 2011-09-22 | 한국콜마 주식회사 | 이부프로펜 함유 서방출성 시럽제 및 그의 제조방법 |
| CN101961306B (zh) * | 2009-07-24 | 2011-11-09 | 北京化工大学 | 一种低熔点药物固体分散体的制备方法 |
| CN102144982B (zh) * | 2011-03-30 | 2012-12-12 | 江苏神龙药业有限公司 | 一种米诺膦酸片及其制备方法 |
| CN102406940B (zh) * | 2011-11-01 | 2013-07-03 | 温州大学 | 一种纳米级片状羧甲基淀粉钠在固体分散体中的应用 |
| WO2013154511A1 (en) * | 2012-04-13 | 2013-10-17 | Mahmut Bilgic | Film tablet formulations comprising dexibuprofen |
| UY36046A (es) | 2014-03-26 | 2015-10-30 | Millennium Pharm Inc | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso |
| JP6647902B2 (ja) * | 2015-10-30 | 2020-02-14 | 株式会社ファンケル | 徐放性顆粒剤 |
| CN106265522A (zh) * | 2016-08-30 | 2017-01-04 | 铜陵翔宇商贸有限公司 | 布洛芬‑pvp共沉淀物及其制备方法 |
| JP7109255B2 (ja) * | 2017-05-23 | 2022-07-29 | ライオン株式会社 | 粉砕物の製造方法及び錠剤の製造方法 |
| JP7147262B2 (ja) * | 2017-05-23 | 2022-10-05 | 大正製薬株式会社 | 固形製剤 |
| US10792249B2 (en) * | 2017-07-24 | 2020-10-06 | Acryspharm Llc | High drug loading pharmaceutical compositions |
| RU2685294C1 (ru) * | 2018-05-10 | 2019-04-17 | Общество с ограниченной ответственностью "ДИНОН" (ООО "ДИНОН") | Поглотитель, способ его приготовления (варианты) и способ удаления диоксида углерода из газовых смесей |
| CN112263567B (zh) * | 2020-10-19 | 2022-05-03 | 南京易亨制药有限公司 | 一种布洛芬缓释胶囊及制备方法 |
| CN117363320B (zh) * | 2023-12-07 | 2024-02-13 | 黑龙江省鑫博鑫交通科技有限公司 | 一种公路用融雪剂及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56120616A (en) * | 1980-02-27 | 1981-09-22 | Kaken Pharmaceut Co Ltd | Ibuprofen-containing granule, its preparation, and internal medicine comprising it |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| CH669523A5 (https=) * | 1986-06-25 | 1989-03-31 | Mepha Ag | |
| US4806359A (en) * | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
| DE19509807A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
| IE80467B1 (en) * | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
| US6391338B1 (en) * | 1995-09-07 | 2002-05-21 | Biovail Technologies Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| DE19536394A1 (de) * | 1995-09-29 | 1997-04-03 | Basf Ag | Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze |
| MX9801835A (es) * | 1996-07-08 | 1998-08-30 | Mendell Co Inc Edward | Matriz de liberacion sostenida para medicamentos insolubles de dosis altas. |
| US6787157B1 (en) * | 1998-03-10 | 2004-09-07 | Abbott Laboratories | Multiphase active ingredient-containing formulations |
| US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
| US8124124B2 (en) * | 1999-12-09 | 2012-02-28 | Reckitt Benckiser Healthcare (Uk) Limited | Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods |
| GB0113839D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
-
2006
- 2006-12-18 ZA ZA200806138A patent/ZA200806138B/xx unknown
- 2006-12-18 CA CA2633266A patent/CA2633266C/en not_active Expired - Fee Related
- 2006-12-18 US US12/097,299 patent/US20080292702A1/en not_active Abandoned
- 2006-12-18 NZ NZ569813A patent/NZ569813A/en not_active IP Right Cessation
- 2006-12-18 AU AU2006325658A patent/AU2006325658B2/en not_active Ceased
- 2006-12-18 WO PCT/KR2006/005526 patent/WO2007069874A1/en not_active Ceased
- 2006-12-18 EP EP06824193.4A patent/EP1968542B1/en not_active Not-in-force
- 2006-12-18 BR BRPI0619868A patent/BRPI0619868A8/pt not_active IP Right Cessation
- 2006-12-18 JP JP2008545503A patent/JP2009519326A/ja active Pending
- 2006-12-18 RU RU2008129041/15A patent/RU2403013C2/ru not_active IP Right Cessation
- 2006-12-18 CN CN2006800474904A patent/CN101330904B/zh not_active Expired - Fee Related
- 2006-12-18 ES ES06824193T patent/ES2429097T3/es active Active
-
2008
- 2008-05-29 IL IL191804A patent/IL191804A0/en unknown
- 2008-07-15 NO NO20083151A patent/NO339674B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1968542A4 (en) | 2010-06-02 |
| JP2009519326A (ja) | 2009-05-14 |
| CA2633266A1 (en) | 2007-06-21 |
| BRPI0619868A2 (pt) | 2011-10-25 |
| HK1126671A1 (en) | 2009-09-11 |
| IL191804A0 (en) | 2008-12-29 |
| ES2429097T3 (es) | 2013-11-13 |
| NO20083151L (no) | 2008-09-05 |
| NO339674B1 (no) | 2017-01-23 |
| AU2006325658A1 (en) | 2007-06-21 |
| CN101330904B (zh) | 2012-04-18 |
| WO2007069874A1 (en) | 2007-06-21 |
| CN101330904A (zh) | 2008-12-24 |
| RU2403013C2 (ru) | 2010-11-10 |
| ZA200806138B (en) | 2009-11-25 |
| EP1968542A1 (en) | 2008-09-17 |
| EP1968542B1 (en) | 2013-08-14 |
| RU2008129041A (ru) | 2010-01-27 |
| US20080292702A1 (en) | 2008-11-27 |
| NZ569813A (en) | 2011-07-29 |
| AU2006325658B2 (en) | 2010-04-08 |
| BRPI0619868A8 (pt) | 2016-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2633266C (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
| Tran et al. | Controlled release systems containing solid dispersions: strategies and mechanisms | |
| JP3045924B2 (ja) | 放出が調整された経口薬剤調合物 | |
| JP5632367B2 (ja) | Ｂｉｂｗ２９９２を含有する固形医薬製剤 | |
| JP4969104B2 (ja) | 多孔質セルロース凝集体及びその成型体組成物 | |
| HU220075B (hu) | Hosszan tartó hatóanyag-leadású morfintartalmú gyógyszerkészítmények és eljárás ezek előállítására | |
| US12427113B2 (en) | Cellulose composition, tablet, and orally disintegrating tablet | |
| KR20070119700A (ko) | 페노피브레이트 및 계면 활성제 혼합물을 함유하는 제제 | |
| JP7028927B2 (ja) | 顆粒の静電量を低減させる方法 | |
| JP2021075686A (ja) | セルロース組成物、錠剤及び口腔内崩壊錠 | |
| KR20000069356A (ko) | 급속방출식 약물전달 제형 | |
| US20230055674A1 (en) | Cellulose composition and tablet | |
| TWI723621B (zh) | 纖維素組合物、錠劑及口腔內崩散錠 | |
| CN116801867A (zh) | 利地利唑的固体片剂剂型 | |
| MX2008007665A (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
| CA3158393C (en) | Cellulose composition, tablet, and orally disintegrating tablet | |
| HK1126671B (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
| CN120676932A (zh) | 贝祖拉替尼制剂 | |
| EP4692178A1 (en) | Cellulose powder and molded body | |
| CN121941725A (zh) | 纤维素粉末及成形体 | |
| Dewedar et al. | FORMULATION AND EVALUATION OF CANDESARTAN CO-PRECIPITATE WITH HYDROPHILIC POLYMERS; PREPARATION OF ORODISPERSIBLE TABLETS | |
| JP2021075687A (ja) | セルロース組成物及び錠剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20181218 |